Medical Communications

Perrigo has rejected Mylan’s hostile $26 billion bid after a 60% majority of shareholders were unconvinced by the terms by …

Dr Mene Pangalos, executive vice president of the IMED Biotech Unit at AstraZeneca UK, has accepted two prestigious appointments that …

The American Heart Association and Google Life Sciences have announced a joint research collaboration to bring ‘unconventional thinking’ to the …

Seven pharma companies have been rated among the world’s 100 most innovative companies, according to Thomson Reuters.The business intelligence firm …

Roche has announced plans to restructure its manufacturing network for small molecules, in a move that will see it mothball …

Boehringer Ingelheim has launched its new research and development strategy, committing €11 billion to R&D over the next five years. …

Pharma’s new-found willingness to embrace all aspects of the digital age, and use it both to its advantage and that …

New data reveals that while antibiotic prescriptions have fallen across England in the last three years, struggling GP practices in …

Boehringer Ingelheim has announced that Professor Andreas Barner will retire as chairman of the Board of Managing Directors on 30 …

A global online survey of doctors released by market research agency Cello Health Insight has indicated that although UK doctors …

The leading pharma players have been able to report largely positive financial results to their shareholders in the third quarter …

AstraZeneca has announced its acquisition of ZS Pharma for an all-cash total of $2.7 billion. In the latest mega-money deal …

Sanofi has paid an initial $300 million for collaboration and license agreement to develop sotagliflozin, one of a newer class …

Sanofi has pledged to plough the money saved from its business restructure into R&D investment, to bring 18 new products …

Merck and Pfizer have commenced an international Phase III study of the investigational cancer immunotherapy avelumab in patients with non-small …